India's drug regulator Drugs Controller General of India has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine months from its manufacturing date.......
The World Health Organisation has rejected Serum Institute of India's proposal seeking extension of the shelf life of Oxford-AstraZeneca COVID-19 vaccine, Covishield, from six to nine months,......
The company had in December said that the CDSCO had approved a 12-month shelf life for Covaxin, which was nine months earlier, reports Sohini Das. IMAGE: A health worker shows off Covaxin vials......
IMAGE: Adar Poonawalla, CEO, Serum Institute of India. Photograph: ANI Photo With only 146 sites conducting vaccinations in India and a few hundred vaccine shots administered every day,......
Pune-based Serum Institute of India (SII) is sitting on 200 million doses of Covishield that were manufactured in December and are set to expire in September. The company is likely to destroy......